PMID: 25287046

Mornon JP, Hoffmann B, Jonic S, Lehn P, Callebaut I
Full-open and closed CFTR channels, with lateral tunnels from the cytoplasm and an alternative position of the F508 region, as revealed by molecular dynamics.
Cell Mol Life Sci. 2015 Apr;72(7):1377-403. doi: 10.1007/s00018-014-1749-2. Epub 2014 Oct 7., [PubMed]
Sentences
No. Mutations Sentence Comment
308 ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 25287046:308:69
status: NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Tyr1073Cys
X
ABCC7 p.Tyr1073Cys 25287046:308:75
status: NEW
view ABCC7 p.Tyr1073Cys details
Of note, a perfect theoretical disulfide bridge in the double mutant F508C/Y1073C should be possible in this particular conformer [Online Resource 21 (B)]. Login to comment
309 ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 25287046:309:109
status: NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 25287046:309:238
status: NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Glu1371Ser
X
ABCC7 p.Glu1371Ser 25287046:309:278
status: NEW
view ABCC7 p.Glu1371Ser details
The existence of the alternative position of F508 was further supported by the fact that the modification of F508C by benzyl-methanethiosulfonate (MTSBn), conserving the F508 aromatic character and restoring gating activity (lost for the F508C mutation in the open state-locked E1371S variant) [76], can be accommodated in both the initial and MD-generated models of CFTR [Online Resource 21 (A)]. Login to comment
346 ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 25287046:346:199
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 25287046:346:233
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 25287046:346:227
status: NEW
view ABCC7 p.Arg347His details
ABCC7 p.Arg352Gln
X
ABCC7 p.Arg352Gln 25287046:346:244
status: NEW
view ABCC7 p.Arg352Gln details
ABCC7 p.Pro205Ser
X
ABCC7 p.Pro205Ser 25287046:346:192
status: NEW
view ABCC7 p.Pro205Ser details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 25287046:346:173
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 25287046:346:213
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 25287046:346:179
status: NEW
view ABCC7 p.Glu92Lys details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 25287046:346:206
status: NEW
view ABCC7 p.Ile336Lys details
ABCC7 p.Asp110His
X
ABCC7 p.Asp110His 25287046:346:185
status: NEW
view ABCC7 p.Asp110His details
ABCC7 p.Ser341Pro
X
ABCC7 p.Ser341Pro 25287046:346:220
status: NEW
view ABCC7 p.Ser341Pro details
First, almost all CF-causing mutations involving residues located in the MSD transmembrane segments are encountered in MSD1 and generally concern positions lining the pore (G85E, E92K, D110H, P205S, R334W, I336K, T338I, S341P, R347H/R347P, and R352Q) (Fig. 7a). Login to comment
348 ABCC7 p.Pro205Ser
X
ABCC7 p.Pro205Ser 25287046:348:49
status: NEW
view ABCC7 p.Pro205Ser details
ABCC7 p.Leu206Trp
X
ABCC7 p.Leu206Trp 25287046:348:13
status: NEW
view ABCC7 p.Leu206Trp details
ABCC7 p.His199Tyr
X
ABCC7 p.His199Tyr 25287046:348:23
status: NEW
view ABCC7 p.His199Tyr details
In addition, L206W and H199Y are situated nearby P205S, orientated toward the lipid bilayer. Login to comment
349 ABCC7 p.Pro67Leu
X
ABCC7 p.Pro67Leu 25287046:349:0
status: NEW
view ABCC7 p.Pro67Leu details
P67L lies in the loop between the N-terminal segment and the N-helix. Login to comment
350 ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 25287046:350:0
status: NEW
view ABCC7 p.Arg74Trp details
R74W (which is reported to be of varying clinical consequence) is located in the vicinity of a large aromatic cluster, including F77, F78, W79, F81, F83, and Y84; the substitution of this arginine by a tryptophan might thus destabilize the local geometry. Login to comment
351 ABCC7 p.Met1101Lys
X
ABCC7 p.Met1101Lys 25287046:351:80
status: NEW
view ABCC7 p.Met1101Lys details
ABCC7 p.Leu927Pro
X
ABCC7 p.Leu927Pro 25287046:351:69
status: NEW
view ABCC7 p.Leu927Pro details
As already hinted to above, only two mutations are observed in MSD2, L927P, and M1101K, which both might disturb the conformation and behavior of the transmembrane helices within the lipid bilayer. Login to comment
352 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25287046:352:77
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 25287046:352:67
status: NEW
view ABCC7 p.Arg117Cys details
Interestingly, amino acid R117, which is involved in the mutations R117C and R117H and is located in the first extracellular loop (ECL1) at the very beginning of TM2, can make a salt bridge with E1124 in ECL6 (distances of 5.5 and 5.8 A da; ) and might thus, among others, participate in the stabilization of the open form of the channel (Fig. 7b). Login to comment
353 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25287046:353:4
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 25287046:353:75
status: NEW
view ABCC7 p.Arg117Cys details
The R117H mutation (varying clinical consequence) appears less severe than R117C (CF-causing), as histidine probably retains part of the attraction with the glutamate E1124 situated at 7.9 A da; . Login to comment
354 ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 25287046:354:213
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Asp110His
X
ABCC7 p.Asp110His 25287046:354:115
status: NEW
view ABCC7 p.Asp110His details
Finally, two CF-causing mutations involve amino acids which are implied in salt bridges: (1) D110 in TM2 (mutation D110H; salt bridge with R1128, distances of 4.0 and 5.0 A da; ) and (2) R334 in ECL3 (mutation R334W; salt bridge with D891, distances of 3.8 and 4.4 A da; ) (Fig. 7b). Login to comment
355 ABCC7 p.Gly970Arg
X
ABCC7 p.Gly970Arg 25287046:355:197
status: NEW
view ABCC7 p.Gly970Arg details
ABCC7 p.Gly178Arg
X
ABCC7 p.Gly178Arg 25287046:355:180
status: NEW
view ABCC7 p.Gly178Arg details
ABCC7 p.Gly178Glu
X
ABCC7 p.Gly178Glu 25287046:355:174
status: NEW
view ABCC7 p.Gly178Glu details
Second, CF-causing mutations in the ICLs involve residues located at the base of the four-helix bundle assembling the four internal ICL helices (symmetric positions in ICL1 (G178E G178R) and ICL3 (G970R), which cannot be substituted by any other amino acid because of steric hindrance reasons (Fig. 7c; Online Resource 2). Login to comment
356 ABCC7 p.Ser945Leu
X
ABCC7 p.Ser945Leu 25287046:356:0
status: NEW
view ABCC7 p.Ser945Leu details
S945L lies within the main lateral tunnel, and might thus impair access to the pore. Login to comment
357 ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 25287046:357:374
status: NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 25287046:357:394
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Leu1065Pro
X
ABCC7 p.Leu1065Pro 25287046:357:154
status: NEW
view ABCC7 p.Leu1065Pro details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 25287046:357:169
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Leu1077Pro
X
ABCC7 p.Leu1077Pro 25287046:357:189
status: NEW
view ABCC7 p.Leu1077Pro details
ABCC7 p.Phe1074Leu
X
ABCC7 p.Phe1074Leu 25287046:357:177
status: NEW
view ABCC7 p.Phe1074Leu details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 25287046:357:162
status: NEW
view ABCC7 p.Arg1066His details
ABCC7 p.Arg560Lys
X
ABCC7 p.Arg560Lys 25287046:357:388
status: NEW
view ABCC7 p.Arg560Lys details
ABCC7 p.Ser492Phe
X
ABCC7 p.Ser492Phe 25287046:357:349
status: NEW
view ABCC7 p.Ser492Phe details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 25287046:357:381
status: NEW
view ABCC7 p.Ala559Thr details
ABCC7 p.His1054Asp
X
ABCC7 p.His1054Asp 25287046:357:138
status: NEW
view ABCC7 p.His1054Asp details
ABCC7 p.Gly1061Arg
X
ABCC7 p.Gly1061Arg 25287046:357:146
status: NEW
view ABCC7 p.Gly1061Arg details
ABCC7 p.Ala561Glu
X
ABCC7 p.Ala561Glu 25287046:357:405
status: NEW
view ABCC7 p.Ala561Glu details
Moreover, a large ''hot spot`` region for natural CFTR mutations is located at the NBD1:ICL4 interface, involving (1) six ICL4 positions (H1054D, G1061R, L1065P, R1066H/R1066C, F1074L, and L1077P), which line the path followed by F508 during the MD1 conformational transition from its initial to its final position, and (2) seven positions in NBD1 (S492F, I507del, F508del, V520F, A559T, R560K/R560T, and A561E) (Fig. 7c). Login to comment
358 ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 25287046:358:96
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 25287046:358:89
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 25287046:358:77
status: NEW
view ABCC7 p.Gly1069Arg details
Some other CFTR mutations of varying clinical consequences, such as F1052 V, G1069R, and R1070W/R1070Q complete the list in this region. Login to comment
359 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 25287046:359:141
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 25287046:359:147
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 25287046:359:154
status: NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Ser1255Pro
X
ABCC7 p.Ser1255Pro 25287046:359:174
status: NEW
view ABCC7 p.Ser1255Pro details
ABCC7 p.Ser1251Asn
X
ABCC7 p.Ser1251Asn 25287046:359:162
status: NEW
view ABCC7 p.Ser1251Asn details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 25287046:359:134
status: NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 25287046:359:127
status: NEW
view ABCC7 p.Ser549Asn details
Third, at the level of the NBD1:NBD2 heterodimer, CF-causing mutations are concentrated within the canonical ATP-binding site (S549N, S549R, G551D/G551S, G1244E, S1251N, and S1255P) (Fig. 7d). Login to comment
360 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 25287046:360:416
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 25287046:360:125
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 25287046:360:174
status: NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 25287046:360:339
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 25287046:360:490
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Leu467Pro
X
ABCC7 p.Leu467Pro 25287046:360:280
status: NEW
view ABCC7 p.Leu467Pro details
The effects of remaining mutations listed in CFTR2 database can also be well understood in light of our structural data: (1) A455E has indeed no room to be well adapted, (2) G1244E (mentioned above) also occurs in a well conserved position (position 23 in Online Resource 2), (3) L467P might disturb the helix in which it is included, (4) G1349D is in the non-canonical ATP-binding site and, alike its corresponding G551D, has no room to be well adapted in presence of ATP, and finally (5) N1303K might disturb the large Q-loop of the NBD2 a-helical subdomain (position 42 in Online Resource 1 and Online Resource 2). Login to comment
362 ABCC7 p.Ile1027Thr
X
ABCC7 p.Ile1027Thr 25287046:362:0
status: NEW
view ABCC7 p.Ile1027Thr details
I1027T faces lipids, but its hydroxyl group likely hides its polarity by establishing a H-bond with the V1024 carbonyl group, within the same helix. Login to comment